【Ideal Scientific Industries】Q1 FY2027 Financial Results | Revenue: ¥2.06 billion (+12.7% YoY)

Financial Performance Overview

In the first quarter of FY2027, Ideal Scientific Industries posted net sales of ¥20,598 million (up 12.7% YoY), operating income of ¥1,588 million (up 7.6%), and net income of ¥13,710 million (up 54.3%). The increase was supported by favorable currency effects from yen depreciation on overseas operations and the acquisition of shares in the Philippine sales subsidiary. Additionally, a ¥520 million gain from the sale of investment securities contributed to higher profits. The segments related to printing equipment showed strong performance domestically and internationally, with increases in both sales and profits.

Outlook and Shareholder Returns

The company maintains its full-year earnings forecast for FY2027 unchanged and will continue to respond swiftly to changes in market conditions. Procurement of raw materials and parts remains stable, and the Company plans to manage profitability despite expected effects of currency fluctuations and rising costs. Share buybacks will be implemented to enhance shareholder returns, with the number of shares outstanding unchanged and treasury stock increasing to ¥10,015 million. Going forward, the Company will focus on expanding overseas operations and new businesses to strengthen its earnings base.